Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Eloxx Pharmaceuticals Inc (NQ: ELOX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eloxx Pharmaceuticals Inc

< Previous 1 2 3 4 5 Next >
Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor
Although getting the boot from an exchange is usually bad news, sometimes there’s a case for delisted stocks to buy. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) shares surged 49.4% to $1.31 in pre-market trading after the company reported a 325% year-over-year growth in its second-quarter revenue. 
Via Benzinga
Eloxx Pharmaceuticals Plans To Take ELX-02 Into Pivotal Trial For Alport Syndrome
Via Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 reverse split on July 10. 
Via Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning! 
Via InvestorPlace
Eloxx, Airbnb, Tesla, PainReform, Roku: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Dow Rises More Than 200 Points; Adial Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 200 points on Tuesday. The Dow traded up 0.73% to 34,193.60 while the NASDAQ rose 0.25% to 13,720.16. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday. 
Via Benzinga
Dow Up 138 Points As Nasdaq Flatlines
Investors are largely expecting the Federal Reserve to hike interest rates by 25 basis points later this month, but the jury is still out as far as its September decision is concerned. 
Via Talk Markets
Why Eloxx Pharmaceuticals (ELOX) Stock Is Soaring Tuesday
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55. 
Via Benzinga
Final Data Report: Eloxx Touts Improved Lung Function For Cystic Fibrosis Candidate
Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) announced the final data assessment from the Phase 2 trial of ELX-02, the company's lead invest 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Gold Down 1.5%; Baidu Earnings Top Estimates
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 250 points on Tuesday. The Dow traded down 0.81% to 33,079.77 while the NASDAQ rose 0.11% to 12,378.50. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nasdaq Edges Higher; Home Depot Posts Downbeat Sales
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.58% to 33,155.20 while the NASDAQ rose 0.24% to 12,394.69. The S&P 500, also... 
Via Benzinga
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. 
Via Benzinga
Why Is Troika (TRKA) Stock Up 31% Today?
Troika Media (TRKA) stock is rising higher on Tuesday after the release of its earnings report for the first quarter of 2023. 
Via InvestorPlace
Why Is Tivic Health Systems (TIVC) Stock Down 28% Today?
Tivic Health Systems (TIVC) stock is sliding lower on Tuesday after the company released its earnings report for the first quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
Eloxx Pharmaceuticals (ELOX) stock is falling hard on Tuesday after the company provided a weak earnings report for Q1 2023. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.